Thursday, 4 June 2026
  
Login

Australia's most trusted
source of pharma news

Thursday, 04 June 2026
News

Pharma winners and losers in Q1

Posted 4 June 2026 AM

Despite headwinds in the headlines, the first quarter of 2026 saw solid growth for the pharmaceutical industry overall, with eight of the top pharmas reporting double digit growth compared to the same period last year.

The list was bookended by obesity giants, with Eli Lilly dominating the market with a 56 per cent growth in revenues for the first quarter this year compared to Q1 in 2025. Fierce Pharma, which compiled the list, noted that this beat the already ambitious analyst consensus estimate by 13 per cent.

To see the whole article, please login


Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (1)

Sales & Customer Relations (20)

Clinical & Medical, R&D (8)

Regulatory, Pharmacovigilance & QA (3)

Other (11)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.